Skip to content

Leadership

Donghoon Lee headshot
Mr. Donghoon Lee is the Chief Executive Officer and President of SK Biopharmaceuticals and its U.S. subsidiaries SK Life Science, Inc. and SK Life Science Labs. His vision is to transform all three companies so that together they become a global biotech leader while generating synergy with SK Group, its affiliates, and partners. Previously, Mr. […]
Read More
Donghoon Lee
Chief Executive Officer and President
Zhihua Sui headshot
Zhihua Sui, Ph.D. is Chief Scientific Officer, Head of Preclinical Research and Development (R&D) at SK Life Science Labs as well as Co-Chair of the Global Research and Development Committee at SK Biopharmaceuticals. Zhihua was the first scientist who joined Proteovant Therapeutics (precursor of SK Life Science Labs) and helped build the R&D Team. Before […]
Read More
Zhihua Sui, Ph.D.
Chief Scientific Officer
Corey Strickland headshot
Dr. Corey Strickland joined SK Life Science Labs in 2021, and is the Vice President of Molecular Technology. Molecular Technology answers the biochemistry, biophysics, proteomics, and structural biology-related questions for drug discovery teams and provides research informatics/IT capabilities. Additionally, Corey plays a critical role in guiding the development of MOPED™, our platform to discover novel […]
Read More
Corey Strickland, Ph.D.
Vice President, Molecular Technology
Helai Mohammad headshot
Helai Mohammad, Ph.D., joined Proteovant Therapeutics, now SK Life Science Labs, in May 2021 as Vice President, Head of Biology. Helai brings more than 20 years of experience in cancer research with 12+ years in the industry. Before joining Proteovant, Helai was at GlaxoSmithKline (GSK) Oncology for ten years in roles with increasing responsibility. In […]
Read More
Helai Mohammad, Ph.D.
Vice President, Head of Biology
Larry J. Jolivette, Ph.D., joined SK Life Science Labs in 2021 and is the Head of the Drug Metabolism & Pharmacokinetics (DMPK) and Safety Assessment functions. With a comprehensive understanding of the drug discovery and development process, Larry plays a critical role in guiding and executing our organization’s preclinical strategy. Before joining SK Life Science […]
Read More
Larry Jolivette, Ph.D.
Vice President, Head of Drug Metabolism and Pharmacokinetics/Safety
Winston Wu headshot
Winston Wu joined Proteovant Therapeutics, now SK Life Science Labs, in August 2021 as Vice President, Head of CMC. Winston has over 30 years of CMC experience in the biotech and pharmaceutical industry. Before joining the company, he spent about 16 years at Lexicon Pharmaceuticals where his most recent position was Vice President of Chemical […]
Read More
Winston Wu, Ph.D.
Vice President, CMC
Dr. Bomie Han joined SK Life Science Labs in 2021 and is the Head of the Integrated Solutions leading a team of diverse expertise encompassing Computational Biology, Computational Chemistry, Mathematical Biology, and Mass Spectrometry. Bomie also leads the development of Sapphire platform for E3-agonistic screening of molecular glue degraders. Before joining the company, Bomie had […]
Read More
Bomie Han, Ph.D.
Executive Director, Head of Integrated Solutions
Kiel Kim is a Vice President of SK Science Inc. as well as the Chief Business Officer, Chief Operating Officer, and board member of SK Life Science Labs. He is responsible for executing the vision of growing SK Life Science Labs into a global biotech company. Previously, Mr. Kim was the Group Leader of Bio […]
Read More
Kiel Kim
Vice President, Business Development
Top